AvKare Eye Drops Recall: FDA Warning & Safety Update
- AvKare, a pharmaceutical company, has initiated a voluntary recall of multiple over-the-counter eye care products, including lubricant eye drops and eye gels.
- While avkare did not specify the exact nature of the deviations, they stated that the issues could range from packaging concerns to manufacturing problems.
- The recall includes the following lubricant eye drops and eye gels:
AvKare is recalling multiple lubricant eye drops and eye gels after an FDA audit revealed regulatory deviations. This voluntary action aims to protect consumers from potentially compromised products, with AvKare citing concerns about unacceptable quality. The affected products include various formulations of lubricant eye drops and eye gels distributed between May 2023 and April 2025; users should promptly discontinue use.Learn what prompted the recall, which specific products are impacted, and how to obtain a refund. News Directory 3 keeps you informed with the latest updates on this developing story. Discover what’s next as this issue unfolds.
“`html
AvKare Issues Recall for Eye Drops Following FDA Audit
Updated May 26, 2025
AvKare, a pharmaceutical company, has initiated a voluntary recall of multiple over-the-counter eye care products, including lubricant eye drops and eye gels. This action follows an audit by the Food and drug Administration (FDA) that revealed regulatory “deviations.” The company cited concerns that these deviations could lead to “products of unacceptable quality,” posing potential risks to patients.
While avkare did not specify the exact nature of the deviations, they stated that the issues could range from packaging concerns to manufacturing problems. The company emphasized that the potential health hazard to users remains unknown, urging consumers to discontinue use of the affected products instantly. The recalled items were distributed between May 26, 2023, and April 21, 2025.
The recall includes the following lubricant eye drops and eye gels:
- NDC# 50268-043-15 Artificial Tears Ophthalmic Solution
- NDC# 50268-066-15 carboxymethylcellulose Sodium Ophthalmic Gel 1%
- NDC# 50268-06